Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on developing and commercializing innovative therapies for high unmet medical needs. Its commercial products include Fanapt (iloperidone) for schizophrenia and bipolar I disorder, HETLIOZ (tasimelteon) for Non-24-Hour Sleep-Wake Disorder and Smith-Magenis syndrome, PONVORY (ponesimod) for relapsing forms of multiple sclerosis, and NEREUS (tradipitant) for prevention of vomiting induced by motion. The company also has pipeline candidates including Bysanti (milsaperidone) and imsidolimab.
Q2 FY2026 — expected 2026-09-28
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-12 | 2025-12-31 | 0001628280-26-007460 | EDGAR | 88K words |
| 2025-02-14 | 2024-12-31 | 0001628280-25-005761 | EDGAR | — |
| 2024-02-08 | 2023-12-31 | 0001628280-24-003785 | EDGAR | — |
| 2023-02-09 | 2022-12-31 | 0001628280-23-002857 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001628280-22-003629 | EDGAR | — |
| 2021-02-11 | 2020-12-31 | 0001347178-21-000005 | EDGAR | — |
| 2020-02-26 | 2019-12-31 | 0001347178-20-000003 | EDGAR | — |
| 2019-02-19 | 2018-12-31 | 0001347178-19-000003 | EDGAR | — |
| 2018-02-15 | 2017-12-31 | 0001193125-18-046425 | EDGAR | — |
| 2017-02-17 | 2016-12-31 | 0001193125-17-047317 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001628280-26-053855 | EDGAR | — |
| 2025-10-30 | 2025-09-30 | 0001628280-25-047317 | EDGAR | 26K words |
| 2025-07-31 | 2025-06-30 | 0001628280-25-036861 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001628280-25-023448 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001628280-24-045970 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0001628280-24-033866 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001628280-24-021952 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001628280-23-038029 | EDGAR | — |
| 2023-07-28 | 2023-06-30 | 0001628280-23-026000 | EDGAR | — |
| 2023-05-03 | 2023-03-31 | 0001628280-23-015267 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001628280-22-027951 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001628280-22-020848 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001628280-26-053308 | EDGAR | — |
| 2026-04-02 | 0001628280-26-023222 | EDGAR | 1K words |
| 2026-03-10 | 0001628280-26-016516 | EDGAR | — |
| 2026-02-23 | 0001628280-26-010376 | EDGAR | — |
| 2026-02-19 | 0001628280-26-009805 | EDGAR | — |
| 2026-02-11 | 0001628280-26-007256 | EDGAR | — |
| 2026-01-08 | 0001628280-26-001273 | EDGAR | — |
| 2025-12-31 | 0001628280-25-059155 | EDGAR | — |
| 2025-12-04 | 0001628280-25-055393 | EDGAR | — |
| 2025-11-28 | 0001628280-25-054225 | EDGAR | — |
364 total filings indexed. 332 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001347178 |
| Ticker | VNDA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.vandapharma.com |
| Listed | 2006-04-12 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/VNDA (~200 tokens, structured JSON with cryptographic provenance)